Recently, numerous calves showing retarded growth and intermittent diarrhea, accompanied by pronounced hypocholesterolemia and low triglyceride concentrations, were observed in the global Holstein population (Kipp *et al*. [2016](#age12801-bib-0006){ref-type="ref"}; Mock *et al*. [2016](#age12801-bib-0009){ref-type="ref"}; Schütz *et al*. [2016](#age12801-bib-0011){ref-type="ref"}). This previously unknown fat metabolism disorder was termed cholesterol deficiency (CD; OMIA 001965‐9913). After a genome‐wide association study uncovering a disease‐associated haplotype on chromosome 11 (Kipp *et al*. [2016](#age12801-bib-0006){ref-type="ref"}), a 1.3‐kb insertion of a transposable LTR element in the coding sequence of the bovine *APOB* gene was identified as a disease‐causing variant (Menzi *et al*. [2016](#age12801-bib-0008){ref-type="ref"}). These findings were independently confirmed (Charlier [2016](#age12801-bib-0001){ref-type="ref"}; Schütz *et al*. [2016](#age12801-bib-0011){ref-type="ref"}). So far, the defect is clinically identifiable only in the homozygote form: Kipp *et al*. ([2016](#age12801-bib-0006){ref-type="ref"}) reported nine cases homozygous for the disease‐associated haplotype, and Duff *et al*. ([2016](#age12801-bib-0003){ref-type="ref"}), Mock *et al*. ([2016](#age12801-bib-0009){ref-type="ref"}) and Schütz *et al*. ([2016](#age12801-bib-0011){ref-type="ref"}) reported one, six and nine *APOB* homozygote mutant cases respectively. The disease‐associated haplotype carrying the *APOB* variant traces back to the North American bull, Maughlin Storm, born in 1991 and used extensively in the Holstein population worldwide (VanRaden & Null [2015](#age12801-bib-0013){ref-type="ref"}). The bovine *APOB* variant represents a loss of function mutation similar to *APOB*‐associated familial hypobetalipoproteinemia‐1, showing incomplete penetrance with respect to expression of clinical signs by a particular age of the affected people (OMIM 615558). Therefore, it was assumed that the bovine *APOB*‐associated CD defect could be explained by an autosomal monogenic recessive mode of inheritance, although clinically normal *APOB* heterozygotes showed reduced cholesterol and triglyceride blood concentrations, indicating a possible codominant inheritance for cholesterol and triglyceride levels (Gross *et al*. [2016](#age12801-bib-0005){ref-type="ref"}; Kipp *et al*. [2016](#age12801-bib-0006){ref-type="ref"}; Saleem *et al*. [2016](#age12801-bib-0010){ref-type="ref"}).

Since the identification of the causal variant in the *APOB* gene, we genotyped a total of 91 Holstein calves that appeared much smaller than their contemporaries, had owner‐reported clinical signs of chronic diarrhea and illthrift, and from which blood samples were submitted for diagnostic purposes ([S2](#age12801-sup-0002){ref-type="supplementary-material"}). In addition, some owners of these 91 calves were suspicious of CD based on the fact that both parents were related to Maughlin Storm. The age of these 91 cases varied from two to 921 days with a mean of 84.8 and a median of 47 ([S1](#age12801-sup-0001){ref-type="supplementary-material"}). Genomic DNA was extracted from EDTA‐stabilized blood samples using the Maxwell instrument (Promega) and analyzed with the direct test targeting the *APOB* variant according to Menzi *et al*. ([2016](#age12801-bib-0008){ref-type="ref"}). The three possible *APOB* genotypes (CDF: non‐carrier; CDC: heterozygous carrier; CDS: homozygous carrier) are presented according to standards of the World Holstein Friesian Federation ([\[Link\]](#age12801-bib-0014){ref-type="ref"}). About 80% of the submitted calves (73/91) were genotyped as homozygous mutant (CDS), confirming the initial suspicion of CD. Interestingly, 20% of clinically affected calves (18/91) were heterozygous mutant (CDC). The mean age of diagnosis of the 73 CDS affected calves was 69 days (SD ± 109.59), and for the 18 CDC clinically affected calves 148 days (SD ± 173.83), which did not differ significantly ([S1](#age12801-sup-0001){ref-type="supplementary-material"}).

Besides the six *APOB*‐homozygous mutant CD‐affected animals reported earlier (Mock *et al*. [2016](#age12801-bib-0009){ref-type="ref"}), we were able to examine an additional 15 CD‐suspect calves clinically ([S2](#age12801-sup-0002){ref-type="supplementary-material"}). Six of these 15 cases were genotyped as CDS, whereas nine were CDC. The clinical phenotype of all 15 cases included poor development, low weight and intermittent diarrhea, as reported before (Mock *et al*. [2016](#age12801-bib-0009){ref-type="ref"}). Laboratory examinations for rotavirus, coronavirus, bovine viral diarrhea virus, coccidia, cryptosporidia, *E. coli* and *Salmonella* spp. gave negative results, and symptomatic treatments did not lead to clinical improvement. Three affected animals with the CDC genotype were euthanized, and the pathological phenotype of these animals was similar to what we have observed before in CDS‐affected cases (Mock *et al*. [2016](#age12801-bib-0009){ref-type="ref"}).

Eleven of the 12 *APOB* homozygous mutant CD‐affected animals had cholesterol and triglyceride readings ([S2](#age12801-sup-0002){ref-type="supplementary-material"}). Mean blood total cholesterol \[norm based on Mock *et al*. ([2016](#age12801-bib-0009){ref-type="ref"}): 1.20--3.84 mmol/l\] for the 11 CDS cases was 0.21 mmol/l (SD ± 0.09), whereas the mean value for the nine CDC affected calves was 1.34 mmol/l (SD ± 0.76) ([S2](#age12801-sup-0002){ref-type="supplementary-material"}). The mean measured blood triglyceride concentration \[norm based on Mock *et al*. ([2016](#age12801-bib-0009){ref-type="ref"}): 0.19--0.51 mmol/l\] was 0.07 mmol/l (SD ± 0.02) for the 11 CDS cases and 0.17 mmol/l (SD ± 0.11) for the nine CDC affected calves ([S2](#age12801-sup-0002){ref-type="supplementary-material"}). These values for total blood cholesterol and triglycerides were subsequently compared with similar data from adult Holstein males determined in the course of a previous study (Gross *et al*. [2016](#age12801-bib-0005){ref-type="ref"}). That control cohort of 254 artificial insemination sires included 218 bulls genotyped as CDF and 36 as CDC ([S2](#age12801-sup-0002){ref-type="supplementary-material"}). A one‐way ANOVA with total cholesterol and triglyceride concentrations as the response variables and the different *APOB* genotypes (CDS, CDC, CDF) in combination with the clinical status of the animals (CD‐affected, non‐affected) as the explanatory variable resulting in four groups (CDS‐affected, CDC‐affected, CDC‐normal, CDF‐normal), was conducted with the Anova function of the [car]{.smallcaps} package (Fox & Weisberg [2011](#age12801-bib-0004){ref-type="ref"}). The significant outcome for total blood cholesterol (*F* = 96.51, DF = 270, *P* \< 2.2e‐16) and triglyceride concentrations (*F* = 10.6, DF = 270, *P* = 1.311e‐06) led to the interpretation that at least both means differed significantly among *APOB* genotypes (Fig. [1](#age12801-fig-0001){ref-type="fig"}). To further investigate the differences between the genotypes, a post‐hoc Tukey test was performed. The function imple.glht from the [mixlm]{.smallcaps} package (Liland [2018](#age12801-bib-0007){ref-type="ref"}) was used for the pairwise comparisons. The pairwise comparison showed a significant difference in blood total cholesterol concentrations between the non‐affected CDC controls and the CD‐affected CDC cases ([S3](#age12801-sup-0003){ref-type="supplementary-material"}). This effect was not observed in triglyceride concentrations, as there was more variation in the triglyceride levels in the CD‐affected animals than in any other group. The distribution of total cholesterol and triglyceride levels for the four groups investigated in the ANOVA is shown in Fig. [1](#age12801-fig-0001){ref-type="fig"}. In comparing the four groups, a tendency of total cholesterol concentrations increasing with each additional copy of the *APOB* wild‐type allele (Fig. [1](#age12801-fig-0001){ref-type="fig"}) was observed, indicating an additive (codominant) effect. However, a significant difference was also observed between the two groups of animals with the CDC genotype (affected vs. non‐affected; est = 0.909 with SE ± 0.166, *z*‐value = 5.465, *P *\< 0.0001) in the pairwise comparison (Fig. [1](#age12801-fig-0001){ref-type="fig"}).

Based on these observations, we assume that an animal with a single copy of the *APOB* variant might show the CD disease due to disturbed lipid homeostasis. Based on our observations, most likely some of these individuals show a fatal inability to maintain a blood cholesterol level sufficient for life. On the other hand, it is known that the cholesterol level is age‐dependent and that the cholesterol level in cattle levels off at about 21 days of age (Shope [1928](#age12801-bib-0012){ref-type="ref"}), and the values of the nine CDC affected calves were determined much later in life (S1). Nonetheless, the CDC‐clinically affected animals were noted much earlier by the owners, at a similar age as the CDS‐clinically affected cases, mostly during the first weeks of life when they were fed milk ([S1](#age12801-sup-0001){ref-type="supplementary-material"}). Nonetheless, most heterozygous animals develop normally, and therefore the mutation acts most likely as incomplete dominance with reduced penetrance in heterozygotes. As all homozygotes develop the clinical disorder, the penetrance of the *APOB* variant is fully complete in homozygotes. On the other hand, only some heterozygotes show a clinical phenotype, meaning that penetrance is incomplete in heterozygotes. Recent findings in human genetics indicate that incomplete penetrance for presumed Mendelian diseases is likely more common than previously believed (Chen *et al*. [2016](#age12801-bib-0002){ref-type="ref"}). Alternatively, possible allelic and/or genetic heterogeneity could also explain the occurrence of the CD disease in some *APOB* heterozygotes
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We conclude that cholesterol deficiency not only affects *APOB* mutant homozygotes but occurs also in heterozygotes. The CD‐affected heterozygous animals can show clinical signs similar to the homozygous mutants. Furthermore, we showed a significant difference in blood total cholesterol and triglyceride concentrations between clinically CD‐affected and non‐affected *APOB* heterozygous animals. Therefore, these findings support an incomplete dominance mode of inheritance with incomplete penetrance in heterozygotes.
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**Figure S1.** Boxplots showing the age distribution in 91 CD‐affected and 254 non‐affected Holstein cattle.
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**Table S1.** List of animals used in the study.
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**Table S2.** Output of the Tukey test showing the pairwise comparisons in detail.
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